Cargando…
Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity()()
In this study, a new compound, 4-(N)-docosahexaenoyl 2′, 2′-difluorodeoxycytidine (DHA-dFdC), was synthesized and characterized. Its antitumor activity was evaluated in cell culture and in mouse models of pancreatic cancer. DHA-dFdC is a poorly soluble, pale yellow waxy solid, with a molecular mass...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965255/ https://www.ncbi.nlm.nih.gov/pubmed/26806350 http://dx.doi.org/10.1016/j.neo.2015.11.012 |
_version_ | 1783325328550133760 |
---|---|
author | Naguib, Youssef W. Lansakara-P., Dharmika Lashinger, Laura M. Rodriguez, B. Leticia Valdes, Solange Niu, Mengmeng Aldayel, Abdulaziz M. Peng, Lan Hursting, Stephen D. Cui, Zhengrong |
author_facet | Naguib, Youssef W. Lansakara-P., Dharmika Lashinger, Laura M. Rodriguez, B. Leticia Valdes, Solange Niu, Mengmeng Aldayel, Abdulaziz M. Peng, Lan Hursting, Stephen D. Cui, Zhengrong |
author_sort | Naguib, Youssef W. |
collection | PubMed |
description | In this study, a new compound, 4-(N)-docosahexaenoyl 2′, 2′-difluorodeoxycytidine (DHA-dFdC), was synthesized and characterized. Its antitumor activity was evaluated in cell culture and in mouse models of pancreatic cancer. DHA-dFdC is a poorly soluble, pale yellow waxy solid, with a molecular mass of 573.3 Da and a melting point of about 96°C. The activation energy for the degradation of DHA-dFdC in an aqueous Tween 80–based solution is 12.86 kcal/mol, whereas its stability is significantly higher in the presence of vitamin E. NCI-60 DTP Human Tumor Cell Line Screening revealed that DHA-dFdC has potent and broad-spectrum antitumor activity, especially in leukemia, renal, and central nervous system cancer cell lines. In human and murine pancreatic cancer cell lines, the IC(50) value of DHA-dFdC was up to 10(5)-fold lower than that of dFdC. The elimination of DHA-dFdC in mouse plasma appeared to follow a biexponential model, with a terminal phase t(1/2) of about 58 minutes. DHA-dFdC significantly extended the survival of genetically engineered mice that spontaneously develop pancreatic ductal adenocarcinoma. In nude mice with subcutaneously implanted human Panc-1 pancreatic tumors, the antitumor activity of DHA-dFdC was significantly stronger than the molar equivalent of dFdC alone, DHA alone, or the physical mixture of them (1:1, molar ratio). DHA-dFdC also significantly inhibited the growth of Panc-1 tumors orthotopically implanted in the pancreas of nude mice, whereas the molar equivalent dose of dFdC alone did not show any significant activity. DHA-dFdC is a promising compound for the potential treatment of cancers in organs such as the pancreas. |
format | Online Article Text |
id | pubmed-5965255 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Neoplasia Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-59652552018-05-31 Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity()() Naguib, Youssef W. Lansakara-P., Dharmika Lashinger, Laura M. Rodriguez, B. Leticia Valdes, Solange Niu, Mengmeng Aldayel, Abdulaziz M. Peng, Lan Hursting, Stephen D. Cui, Zhengrong Neoplasia Article In this study, a new compound, 4-(N)-docosahexaenoyl 2′, 2′-difluorodeoxycytidine (DHA-dFdC), was synthesized and characterized. Its antitumor activity was evaluated in cell culture and in mouse models of pancreatic cancer. DHA-dFdC is a poorly soluble, pale yellow waxy solid, with a molecular mass of 573.3 Da and a melting point of about 96°C. The activation energy for the degradation of DHA-dFdC in an aqueous Tween 80–based solution is 12.86 kcal/mol, whereas its stability is significantly higher in the presence of vitamin E. NCI-60 DTP Human Tumor Cell Line Screening revealed that DHA-dFdC has potent and broad-spectrum antitumor activity, especially in leukemia, renal, and central nervous system cancer cell lines. In human and murine pancreatic cancer cell lines, the IC(50) value of DHA-dFdC was up to 10(5)-fold lower than that of dFdC. The elimination of DHA-dFdC in mouse plasma appeared to follow a biexponential model, with a terminal phase t(1/2) of about 58 minutes. DHA-dFdC significantly extended the survival of genetically engineered mice that spontaneously develop pancreatic ductal adenocarcinoma. In nude mice with subcutaneously implanted human Panc-1 pancreatic tumors, the antitumor activity of DHA-dFdC was significantly stronger than the molar equivalent of dFdC alone, DHA alone, or the physical mixture of them (1:1, molar ratio). DHA-dFdC also significantly inhibited the growth of Panc-1 tumors orthotopically implanted in the pancreas of nude mice, whereas the molar equivalent dose of dFdC alone did not show any significant activity. DHA-dFdC is a promising compound for the potential treatment of cancers in organs such as the pancreas. Neoplasia Press 2016-01-21 /pmc/articles/PMC5965255/ /pubmed/26806350 http://dx.doi.org/10.1016/j.neo.2015.11.012 Text en © 2015 Institut National de la Santé Et de la Recherche Médicale http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Naguib, Youssef W. Lansakara-P., Dharmika Lashinger, Laura M. Rodriguez, B. Leticia Valdes, Solange Niu, Mengmeng Aldayel, Abdulaziz M. Peng, Lan Hursting, Stephen D. Cui, Zhengrong Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity()() |
title | Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity()() |
title_full | Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity()() |
title_fullStr | Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity()() |
title_full_unstemmed | Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity()() |
title_short | Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity()() |
title_sort | synthesis, characterization, and in vitro and in vivo evaluations of 4-(n)-docosahexaenoyl 2′, 2′-difluorodeoxycytidine with potent and broad-spectrum antitumor activity()() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965255/ https://www.ncbi.nlm.nih.gov/pubmed/26806350 http://dx.doi.org/10.1016/j.neo.2015.11.012 |
work_keys_str_mv | AT naguibyoussefw synthesischaracterizationandinvitroandinvivoevaluationsof4ndocosahexaenoyl22difluorodeoxycytidinewithpotentandbroadspectrumantitumoractivity AT lansakarapdharmika synthesischaracterizationandinvitroandinvivoevaluationsof4ndocosahexaenoyl22difluorodeoxycytidinewithpotentandbroadspectrumantitumoractivity AT lashingerlauram synthesischaracterizationandinvitroandinvivoevaluationsof4ndocosahexaenoyl22difluorodeoxycytidinewithpotentandbroadspectrumantitumoractivity AT rodriguezbleticia synthesischaracterizationandinvitroandinvivoevaluationsof4ndocosahexaenoyl22difluorodeoxycytidinewithpotentandbroadspectrumantitumoractivity AT valdessolange synthesischaracterizationandinvitroandinvivoevaluationsof4ndocosahexaenoyl22difluorodeoxycytidinewithpotentandbroadspectrumantitumoractivity AT niumengmeng synthesischaracterizationandinvitroandinvivoevaluationsof4ndocosahexaenoyl22difluorodeoxycytidinewithpotentandbroadspectrumantitumoractivity AT aldayelabdulazizm synthesischaracterizationandinvitroandinvivoevaluationsof4ndocosahexaenoyl22difluorodeoxycytidinewithpotentandbroadspectrumantitumoractivity AT penglan synthesischaracterizationandinvitroandinvivoevaluationsof4ndocosahexaenoyl22difluorodeoxycytidinewithpotentandbroadspectrumantitumoractivity AT hurstingstephend synthesischaracterizationandinvitroandinvivoevaluationsof4ndocosahexaenoyl22difluorodeoxycytidinewithpotentandbroadspectrumantitumoractivity AT cuizhengrong synthesischaracterizationandinvitroandinvivoevaluationsof4ndocosahexaenoyl22difluorodeoxycytidinewithpotentandbroadspectrumantitumoractivity |